ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $65 | -90.7% | 66,770 | -86.7% | 0.00% | -85.7% |
Q2 2023 | $696 | +2220.0% | 500,769 | +2478.2% | 0.01% | – |
Q1 2023 | $30 | -75.6% | 19,423 | -2.2% | 0.00% | -100.0% |
Q4 2022 | $123 | -100.0% | 19,856 | -57.0% | 0.00% | -33.3% |
Q3 2022 | $309,000 | +45.8% | 46,195 | +38.0% | 0.00% | +50.0% |
Q2 2022 | $212,000 | -82.0% | 33,466 | -85.8% | 0.00% | -71.4% |
Q4 2021 | $1,177,000 | -47.1% | 235,475 | +27.5% | 0.01% | -50.0% |
Q3 2021 | $2,225,000 | +448.0% | 184,684 | +2606.0% | 0.01% | -17.6% |
Q4 2019 | $406,000 | – | 6,825 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |